A team of researchers led by Katalin Susztak, MD, PhD, the Willard and Rhoda Ware Professor of Diabetes and Metabolic Disease at Penn Medicine, are developing a blood test to better predict the risk of kidney disease in Black Americans who carry high-risk APOL1 gene variants, allowing more effective monitoring and treatment. To learn more about investment and partnership opportunities, please contact Kultaran Chohan, PhD, Executive Director of Licensing for PSOM. Read more here.